SCHEMBL5287

SCHEMBL5287

O[C@]1(Cc2ccccc2)CC[C@]2(CCN(c3ccc(OC(F)(F)F)cc3)C2)CC1

nearest known ligand 0.45

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 9/20 0.44
AR P10275 1/20 0.41
LIPE Q05469 2/20 0.41
PKLR P30613 1/20 0.41
CHRM2 P08172 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5614 0.82 LIPE (0.60) LIPEEPHX2
SCHEMBL5019 0.80 SLC6A4 (0.49) CHRM4LIPEEPHX2
SCHEMBL748074 0.77 GRM5 (0.55) CHRM4EPHX2
SCHEMBL622213 0.77 FFAR4 (0.46) EPHX2
SCHEMBL5301 0.77 EPHX2 (0.42) LIPEEPHX2
SCHEMBL5663 0.76 LIPE (0.70) LIPE
SCHEMBL1589109 0.76 LIPE (0.70) LIPE
SCHEMBL5662 0.76 LIPE (0.70) LIPE
SCHEMBL26552871 0.76 ALDH1A1 (0.47) EPHX2
SCHEMBL743517 0.75 MAPK1 (0.54) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed